Gender-Related Safety and Outcome in Advanced NSCLC Patients Treated with Immune Checkpoint-Inhibitors. A Real-World Experience

被引：0
|
作者：
Pizzutilo, P. [1 ]
Catino, A. [1 ]
Montrone, M. [1 ]
Longo, V. [1 ]
Ricci, D. [1 ]
Pesola, F. [1 ]
Marech, I. [1 ]
Mastrandrea, A. [1 ]
Petrillo, P. [1 ]
Zacheo, A. [1 ]
Varesano, N. [1 ]
Lamorgese, V. [1 ]
Bafunno, D. [1 ]
Galetta, D. [1 ]
机构：
[1] IRCCS Ist Tumori Giovanni Paolo II, Thorac Oncol, Thorac Oncol Unit, Bari, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Immune checkpoint inhibitors; Gender-related outcome; advanced lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P75.14
引用
收藏
页码：S579 / S580
页数：2
相关论文
共 50 条
  • [31] Treatment with Immune Checkpoint Inhibitors for Advanced NSCLC in Elderly and Frail Patients. A Real-Life Experience
    Junker, K. Fuglsang
    Persson, G.
    Andersen, J. Lykkegaard
    Sorensen, J.
    Langer, S.
    Pohl, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S460 - S461
  • [32] Immune checkpoint inhibitors in advanced non-small cell lung cancer: Real-world survival and safety
    Tang, Monica
    Lee, Chee
    Lewis, Craig
    Boyer, Michael
    Brown, Bernadette
    Schaffer, Andrea
    Pearson, Sallie-Anne
    Simes, Robert
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 30 - 31
  • [33] Real-world data in the era of immune checkpoint inhibitors
    Narita, Yukiya
    ANNALS OF ONCOLOGY, 2021, 32 : S250 - S250
  • [34] Myositis with immune checkpoint inhibitors in a real-world setting
    Reactions Weekly, 2020, 1794 (1) : 11 - 11
  • [35] Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy
    Gupta, Vineet Govinda
    Rangaraju, Ranga Rao
    Abbas, Waseem
    Bajpai, Peush
    Khetrapal, Ruchika
    SOUTH ASIAN JOURNAL OF CANCER, 2019, 8 (01) : 65 - 68
  • [36] Khorana risk score in lung cancer patients treated with immune checkpoint inhibitors: a real-world study
    Song, Junmin
    Morgan, Ahmed Ashraf
    Abram, Ana Maria Diaz
    Hong, Daniel
    Kim, Gagi
    Li, Wing Fai
    Ahn, Jaeun
    Chang, Yu
    Chi, Kuan-Yu
    Chiang, Cho-Han
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2025,
  • [37] Association of the LIPI With Survival and Response in Advanced NSCLC Patients Treated With Immune Checkpoint Inhibitors
    Zhi, X.
    Zhang, Z.
    Li, W.
    Yan, X.
    Zhang, F.
    Han, X.
    Yuan, F.
    Ma, J.
    Wang, L.
    Tao, H.
    Li, X.
    Zhang, S.
    Ge, X.
    Hu, Y.
    Wang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S582 - S582
  • [38] Radiomics predicts risk of cachexia in advanced NSCLC patients treated with immune checkpoint inhibitors
    Wei Mu
    Evangelia Katsoulakis
    Christopher J. Whelan
    Kenneth L. Gage
    Matthew B. Schabath
    Robert J. Gillies
    British Journal of Cancer, 2021, 125 : 229 - 239
  • [39] Radiomics predicts risk of cachexia in advanced NSCLC patients treated with immune checkpoint inhibitors
    Mu, Wei
    Katsoulakis, Evangelia
    Whelan, Christopher J.
    Gage, Kenneth L.
    Schabath, Matthew B.
    Gillies, Robert J.
    BRITISH JOURNAL OF CANCER, 2021, 125 (02) : 229 - 239
  • [40] Long-term outcome and safety in patients treated with immune checkpoint blockade therapies for urothelial carcinoma: Experience from real-world clinical practice.
    Tural, Deniz
    Arslan, Cagatay
    Selcukbiricik, Fatih
    Olmez, Omer Fatih
    Erman, Mustafa
    Urun, Yuksel
    Karadurmus, Nuri
    Akar, Emre
    Kilickap, Saadettin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
12345